ICG-A effectively detects low perfusion areas during oncoplastic breast surgery, helping predict skin necrosis and aiding in surgical planning for high-risk patients.
Continue reading
First report of robotic-assisted anatomical liver resection using indocyanine green (ICG) fluorescence and the ultrasound-guided preoperative positive staining technique.
Continue reading
A review of indocyanine green in thoracic surgery, focusing on its use in pulmonary nodule localization, lung segment imaging, and blood supply assessment under NIR technology, enhancing thoracoscopic procedures.
Continue reading
Discover how ICGA reduces complications in head and neck reconstruction by 25.7%, improving patient outcomes in real-time surgical strategies.
Continue reading
The medial sural artery perforator (MSAP) flap is used for hand defect reconstruction, offering thin coverage for full-thickness defects. Post-op care includes anticoagulation and early mobilization
Continue reading
A new protocol combining 99mTc-Tilmanocept and ICG fluorescence enhances sentinel lymph node detection in early oral cancer, improving accuracy in complex areas like the floor of the mouth.
Continue reading
This study presents a robotic technique for bilateral DIEP flap harvest using the da Vinci Xi system and indocyanine green imaging, minimizing abdominal wall disruption. Collaboration with general surgeons is advised for adopting this technique safely.
Continue reading
Systematic review and meta-analysis suggest ICG use during esophagectomy may reduce anastomotic leaks, but study limitations require cautious interpretation.
Continue reading
study shows ICG-NIRF imaging effectively identifies ureters, vessels, and nerves during robot-assisted sacrocolpopexy, enhancing safety and simplifying procedures
Continue reading
Date: September 1, 2024
ICG Product Shortage & Notice of Allocation
Indocyanine Green for Injection USP, 25 mg / Vial, Kit of 5 & 6 packs
We are currently working with our distribution partners to manage pending shortages of ICG. In late June, we initiated an allocation process for all of our distribution partners. This process has been set up and is being administered in a fair and equitable fashion.
Diagnostic Green/Renew Pharmaceuticals, the manufacturer of record is working diligently to alleviate shortages including working with regulatory authorities to support bringing a new manufacturing facility on-line by the end of the year. This action, along with an aggressive recovery action plan with our current manufacturer will ensure that this shortage situation will be remedied by the end of the year.
